Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mitra Shourian"'
Autor:
Mitra Shourian, Salman T. Qureshi
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cryptococcus neoformans is a ubiquitous environmental yeast and a leading cause of invasive fungal infection in humans. The most recent estimate of global disease burden includes over 200,000 cases of cryptococcal meningitis each year. Cryptococcus n
Externí odkaz:
https://doaj.org/article/ed265e33face4a5cb979886da7603c3f
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) are pro-inflammatory cytokines that are induced after Cryptococcus neoformans infection and activate the interleukin-1 receptor type I (IL-1RI). To establish the role of IL-1RI signaling in
Externí odkaz:
https://doaj.org/article/0197519355c843eba206db935b728a37
Autor:
Mitra Shourian, Salman T. Qureshi, Jörg H. Fritz, Roman Istomine, Tho Al-Fakar Al-Aubodah, Fernando Alvarez, Nils Pavey, Ciriaco A. Piccirillo
Publikováno v:
Mucosal Immunology. 12:746-760
CD4+Foxp3+ regulatory T (TREG) cells are critical mediators of peripheral tolerance and modulators of immune responses. Functional adaptation of TREG cells, through acquisition of secondary transcription factors is critical for their effector differe
Publikováno v:
Seminars in immunology. 42
Overcoming exhaustion-associated dysfunctions and generating antigen-specific CD8 T cells with the ability to persist in the host and mediate effective long-term anti-tumor immunity is the final aim of cancer immunotherapy. To achieve this goal, immu
Publikováno v:
The Journal of Immunology. 206:58.06-58.06
T-cell exhaustion and reduced memory potential is an obstacle to successful adoptive cell therapy (ACT) of cancer. Ex-vivo expansion protocols require sustained TCR and cytokine stimulation that limit ACT efficacy and long-term persistence. We have s
Publikováno v:
The Journal of Immunology. 206:58.07-58.07
Immune checkpoint (IC) blockade has revolutionized the treatment of chemo-refractory solid tumors and has demonstrated promising results for the treatment of resistant blood cancers, including lymphoma. However, clinical response to PD1 blockade depe
Autor:
Fernando, Alvarez, Roman, Istomine, Mitra, Shourian, Nils, Pavey, Tho Al-Fakar, Al-Aubodah, Salman, Qureshi, Jörg H, Fritz, Ciriaco A, Piccirillo
Publikováno v:
Mucosal immunology. 12(3)
CD4
Publikováno v:
Frontiers in Immunology
Interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) are pro-inflammatory cytokines that are induced after Cryptococcus neoformans infection and activate the interleukin-1 receptor type I (IL-1RI). To establish the role of IL-1RI signaling in
Publikováno v:
Blood. 134:2806-2806
Background: Immune checkpoint (IC) blockade has revolutionized the treatment of chemo-refractory solid tumors and has demonstrated promising results for the treatment of resistant blood cancers, including lymphoma. However, clinical response to PD1 b
Autor:
Arnold S. Kristof, Sabah N. A. Hussain, Alexandra Triantafillopoulos, Mitra Shourian, Scott F. Carroll, Anders Bondo Dydensborg, Sharon Harel, Jill A. Fielhaber, Maxime Bouchard, Salman T. Qureshi
Publikováno v:
The Journal of Immunology. 188:4535-4542
Acute lung injury during bacterial infection is associated with neutrophilic inflammation, epithelial cell apoptosis, and disruption of the alveolar-capillary barrier. TLR4 is required for lung injury in animals exposed to bacterial LPS and initiates